Atriva Therapeutics GmbH

Atriva Therapeutics’ mission is to develop an antiviral and immunomodulatory therapy platform against severe respiratory and systemic diseases with a high unmet medical need induced by RNA viruses, e.g., influenza, COVID-19, RSV (Respiratory Syncytial Virus) and Dengue.